Friday, 23 July, 2021 - 17:41
Board Moves July 23, 2021
Our board moves wrap includes Geoffrey Xue, Brian Miller, Nic Pollock, Timothy Longstaff, Boaz Wachtel, Adam Blumenthal, and Luca Giacovazzi.
Adam Blumenthal has over 10 years of experience in investment banking and corporate finance, with deep exposure to Australian and International markets, having provided capital raising and financing solutions to an extensive number of unlisted and listed companies.
Mr Blumenthal has played a lead role in advising and supporting multiple organisations across a broad spectrum of industries, using his experience and extensive network of international contacts to provide corporate advisory and capital markets input.
Mr Blumenthal has successfully worked on several medical marijuana deals spanning Israel, Canada and Switzerland. He has also been actively involved in mining, cyber security, health care and IT sectors.
Outside of his formal business activities, Mr Blumenthal has lectured at a leading Sydney University covering corporate governance, corporate social responsibility and ASX listings – at an undergraduate and postgraduate level.
Mr Blumenthal holds a Bachelor of Commerce (B.COM), Master of International Relations (MIR) and Master of Business Administration (MBA) degrees.
Rank | Company | # | |
---|---|---|---|
34th | ![]() |
BWP Trust | $174.46m |
35th | - | Swick Mining Services | $151.05m |
36th | ![]() |
Joyce Corporation | $148.40m |
37th | - | Creso Pharma | $144.65m |
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
1061st | BauMart Holdings">BauMart Holdings | -16% | -17.89% |
1062nd | Helloworld Travel">Helloworld Travel | -16.11% | -10.76% |
1063rd | Creso Pharma">Creso Pharma | -16.35% | -28.59% |
1064th | McPherson's">McPherson's | -16.35% | -28.59% |
1065th | Advanced Health Intelligence">Advanced Health Intelligence | -16.37% | -18.76% |
![]() |
NEWS: Tagged in Board Moves December 20, 2023 | 20 Dec 2023 |
![]() |
REMUNERATION UPDATE: Founder, Non-Executive Director, was Chair till 2021, Creso Pharma | 03 Nov 2020 |
Our board moves wrap includes Geoffrey Xue, Brian Miller, Nic Pollock, Timothy Longstaff, Boaz Wachtel, Adam Blumenthal, and Luca Giacovazzi.
Adam Blumenthal has stood aside as chair of Creso Pharma following notice of an ASIC investigation concerning common directorships between the company and its corporate adviser.
Our board moves wrap includes Colin Beckett, Robert Jager, Ben Quirin, Jodi Scott, Adam Blumenthal, Justin Osborne, Peter Buck, Kathleen Bozanic, Matthew Yates, Craig Williams, Rowan Johnston, and Cristian Moreno.
Our board moves wrap includes Adam Kiley, Warren King, Sam Lee Mohan, David Kelly, Paul Ferguson, Dafna Shalev-Flamm, and Adam Blumenthal.
Position | Company | Year | Company's current rank |
---|---|---|---|
Non-Executive Director, was Chair 2021-2022
|
2017 - 2023 | 168 | |
Founder, Non-Executive Director, was Chair till 2021
|
2015 - 2022 | 37 | |
Non-Executive Director
|
2017 - 2018 | ||
Non-Executive Director
|
- 2014 | ||
Non-Executive Director
|
- | 499 |
Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
---|---|---|---|---|---|---|
2023-10-06 | Issued | 10,833,333 | $0.01 | $65,000 | Other | |
2023-10-06 | Issued | 10,833,333 | $0.00 | Other | ||
2023-01-16 | Other | 4,200,000 | $0.00 | Other | ||
2022-07-24 | Other | 4,535,650 | $0.00 | Other | ||
2021-11-02 | Issued | 37,888,479 | $0.00 | Other |
Company | Direct shares | Indirect shares | Total shares | Total value |
---|---|---|---|---|
76389 | 14393514 | 14469903 | $14.47m |
Announced | Bidder | Target | Transaction Type | Total Value | |
---|---|---|---|---|---|
Creso Pharma | Acquisition | $6.35m | >> |